Skip to main content

US ClosedU.S. Closed

GNPX: Genprex, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages.

52W Range

0thpctl

Volume

0.41×avg

Market Cap

1.85MUSD

P/E Ratio

-0.0TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Genprex, Inc.

GNPXNASDAQ Capital Market·USD·Closed

Genprex, Inc.

GNPXNASDAQ·USD·Closed

$3.67

+1.66%

$3.67

+$0.06 (1.66%)

52W Range

0thpctl

Volume

0.41×avg

Mkt Cap

1.85MUSD

P/E

-0.0TTM

Div Yield

–ann